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Cytokines are known to be important regulators of normal hemopoiesis, acting in concert with 
components of the bone marrow microenvironment.  Interactions with this microenvironment 
are known to regulate the proliferation, differentiation, and homing of hemopoietic progenitor 
(CD34 +) cells. Adhesive interactions with the extracellular matrix retain CD34 + cells in close 
proximity to cytokines, but may also provide important costimulatory signals. Thus, the functional 
states of adhesion receptors are critical properties of CD34 + cells, but the physiological mech- 
anisms responsible for regulating  functional properties of cell adhesion receptors on primitive 
hemopoietic cells are still unknown.  We confirm that the integrins very late antigen (VLA)-4 
and VLA-5 are expressed on the CD34 + cell lines MO7e, TF1,  and on normal bone marrow 
CD34 +  progenitor  cells,  but  in  a  low  affinity  state,  conferring  on  them  a  weak  adhesive 
phenotype on fibronectin (Fn). Herein, we show that the cytokines interleukin (IL)-3, granulocyte- 
macrophage CSF (GM-CSF), and KIT ligand  (KL) are physiological activators of VLA-4 and 
VLA-5 expressed by MO7e, TF1, and normal bone marrow CD34 + progenitor cells. Cytokine- 
stimulated adhesion on Fn is dose dependent and transient,  reaching a maximum between 15 
and 30 min and returning to basal levels after 2 h. This cytokine-dependent activation is specific 
for VLA-4 and VLA-5,  since activation of other ~1 integrins  was not observed. The addition 
of second messenger antagonists staurosporine and W7 abolished all cytokine-stimulated adhesion 
to Fn. In contrast,  genistein inhibited KL-stimulated adhesion, but failed to inhibit GM-CSF- 
and IL-3-stimulated  adhesion.  Our data suggest that cytokines GM-CSF and IL-3 specifically 
stimulate B1 integrin function via an "inside-out" mechanism involving protein kinase activity, 
while KL stimulates integrin  activity through  a similar,  but initially distinct,  pathway via the 
KIT tyrosine-kinase. Thus, in addition to promoting the survival,  proliferation, and development 
of hemopoietic progenitors, cytokines also regulate adhesive interactions between progenitor cells 
and the bone marrow microenvironment by modifying the functional states of specific integrins. 
These  data  are  of importance  in  understanding  the  fundamental  processes  of/~1  integrin 
activation and cellular response to mitogenic cytokines, as well as on the clinical  setting where 
cytokines induce therapeutic  mobilization  of hematopoietic  progenitors. 
I 
n  adults,  normal  hemopoiesis  takes  place  in  the  bone 
marrow,  where hemopoietic progenitors  are retained in 
intimate contact with the stroma. The bone marrow stroma 
constitutes a microenvironmental niche where specific growth 
factors and inhibitors regulate quiescence, proliferation,  and 
differentiation of hemopoietic stem cells (1-3).  Stroma-free 
liquid and semisolid cultures have identified some of the var- 
ious functions that  growth factors (cytokines) and growth 
inhibitors induce in the progenitor population. Some of these 
cytokines, such as IL-1, IL-3, IL-6, and GM-CSF, are active 
in soluble form, whereas others, such as CSF-1 and KIT ligand 
(KL) ~ (stem  cell factor)  can  act  in  soluble or membrane- 
bound forms (for review,  see reference 4). 
Long-term culture of bone marrow progenitors on preestab- 
1 Abbreviations used in this paper: ECM, extracellular matrix proteins; Fn, 
fibronectin; HCCR, Hanson Centre for Cancer Research; HPCA-2-PE, 
PE-conjugated anti-CD34 mAb HPCA-2; KL, KIT ligand; VLA, very 
]ate antigen. 
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of interactions between progenitor cells, stromal cells, and 
elements of the extracellular microenvironment. Such inter- 
actions are essential to sustain the long-term self-renewal of 
very primitive progenitors and support their differentiation 
into committed progenitors. Several studies have shown that 
the interaction of integrin receptors expressed by hemopoietic 
progenitors with their stromal ligands, or counterreceptors, 
is critical for adhesion and homing of myeloid and lymphoid 
progenitors to the bone marrow (for review,  see reference 
5).  This  is  particularly the case  for/31  integrin receptors 
ol4/3t (very late antigen [VLA]-4, CD49d/CD29)  and 0/5/31 
(VLA-5, CD49e/CD29), which interact with fibronectin (Fn) 
and vascular cell adhesion molecule-I, two major components 
of the bone marrow stroma. While VLA-5 is widely expressed, 
VLA-4 is more restricted to normal B and T  cells, thymo  o 
cytes, monocytes, and hemopoietic progenitors (6-9). Teixid6 
et al. (10) have shown that 90% of marrow CD34 hi progen- 
itor cells express  the/31 integrin chain. These ~1 integrins 
are mainly comprised of VLA-4 and VLA-5 complexes, since 
77% and 49%  of CD34 hi cells coexpress  or4 and c~s chains, 
respectively,  with very little expression of czl, o~2, cz3, and 
o~6 chains (9,  10). The importance of VLA-4 in hemopoi- 
esis was first demonstrated by Miyake et al. (11), who reported 
that the addition of anti-VLA-4 mAbs to long-term bone 
marrow cultures abrogated lymphopoiesis and retarded my- 
elopoiesis.  VLA-4-specific antibodies have also been shown 
to abrogate stroma-dependent erythropoiesis (12). Fn has been 
shown to increase the proliferation of burst-forming unit-E, 
CFU-E, and CFU-M, induced by IL-3 and erythropoietin 
in methyl cellulose cultures of enriched CD34 §  cells,  an 
effect reversed by Arg-Gly-Asp-Ser-containing  peptides which 
antagonize the VLA-5/Fn interaction (13, 14). 
Adhesion-stimulated signaling pathways thus appear to be 
an important component of the regulation of cell division 
and differentiation during normal hemopoiesis.  Using hemo- 
poietic progenitor cell  (CD34 §  models, we have investi- 
gated the interrelationship between cytokine-stimulated  path- 
ways and cellular events induced by the interaction of Fn with 
the  /31  integrins,  VLA-4  and VLA-5.  In  this  report,  we 
show that specific cytokines can rapidly and transiently modify 
VLA-4 and VLA-5 function to promote adhesion on Fn in 
two growth factor-dependent myeloid cell lines,  TF1 and 
MO7e,  and in CD34 +  progenitors  purified from normal 
donor bone marrow aspirates. Thus, growth factors may regu- 
late cellular events,  such as cell adhesion, critical to normal 
hemopoiesis, in addition to proliferation and differentiation. 
Materials  and Methods 
Antibodies.  mAbs 61-2C4 and 49-1Bll, identifying the/31 inte- 
grin chain (CD29) and bselectin (CD62L), respectively,  were made 
available by Dr. J. Gamble (Hanson Centre for Cancer Research 
[HCCR], Adelaide,  Australia). Ig directed to IL-3 receptor or-chain 
(CD123), 9F5, and GM-CSF receptor or-chain (CDw116), 8G6, 
were provided  by Dr. A. Lopez (HCCR). YB5.B8, an mAb specific 
for KIT receptor (CDl17)  (15), was kindly provided by Dr. L. 
Ashman (HCCR). P4C2, which binds to VLA-4 (CD49d/CD29), 
blocking adhesive function (16), P3G8, recognizing otv integrin 
chain (CD51), PIB5, recognizing VLA-3 (CD49c/CD29),  and 
P5D2, recognizing/3t  integrin chain, were generously provided 
by Dr. E. Wayner (University of Minnesota Medical School, St. 
Paul, MN). PHM2 (17), a function-blocking  mAb directed  to VLA-5 
(CD49e/CD29), was a gift from Professor  R. A. Aitkins (Monash 
Medical Centre, Melbourne, Australia). The anti-/31 (CD29) inte- 
grin mAb, 8A2, previously  shown to activate/31 integrin function 
(18), was made available  by Drs. J. Harlan and N. Kovach  (Univer- 
sity of Washington, Seattle, WA). PE-conjugated  anti-CD34 mAb 
HPCA-2 (HPCA-2-PE) was purchased from Becton Dickinson & 
Co. (Mountain View, CA). TS2/7 recognizing VLA-1 (CD49a/ 
CD29) and AC11, a blocking anti-VLA-2 (CD49b/CD29),  was 
obtained from the American Type Culture Collection (Rockville, 
MD).  Unless noted otherwise, all antibodies in this study were 
used as a~nity-purified Ig. FITC-conjugated sheep F(ab)'2 frag- 
ments, directed toward mouse Ig, were purchased from Silenus 
Laboratories Pty., Ltd. (Hawthorn,  Australia). 
Chemicals and Cytokines.  Recombinant human KL, IL-1, IL-3, 
IL-6, GM-CSF, and G-CSF were generously provided by Amgen 
Biologicals (Thousand Oaks, CA). Laminin and type IV collagens 
were purchased from Collaborative Biomedical Products/Becton 
Dickinson Labware  (Bedford,  MA). Human Fn was purchased from 
Boehringer Mannheim (Mannheim, Germany). Vitronectin was 
a generous gift from Dr. G. Burns (Royal Newcastle Hospital, 
Newcastle, Australia) and rat tail collagen I was from Dr. P. Kaur 
(Institute of Medical and Veterinary  Science, Adelaide, Australia). 
Second messenger inhibitors staurosporine, W7, genistein, and 
calyculin A were purchased from Calbiochem-Novabiochem  (San 
Diego,  CA);  okadaic acid and cholera toxin were from Sigma 
Chemical Co. (St. Louis, MO). All culture media were purchased 
from Life Technologies  (Glen Waverley,  Australia). BSA was from 
Commonwealth Serum Laboratories (Parkville, Australia). 
Cell Lines.  The erythroleukemia-derived  cell line TF1 (19) was 
routinely grown in RPMI 1640 medium supplemented with 1007o 
non-heat-denatured FCS, 10 mM Hepes, 1 mM sodium pyruvate, 
2 mM L-glutamine,  penicillin, gentamycin, and 2 ng/ml GM-CSF. 
The megakaryocytic  leukemia-derived  cell line MO7e (20) was rou- 
tinely grown in DMEM, supplemented with 10~  FCS, 10 mM 
Hepes, 2 mM L-glutamine, penicillin, gentamycin, and 10 ng/ml 
IL-3. Both cell lines were shown to be mycoplasma-free  by using 
the Mycoplasma  TC Rapid Detection System (Gen-Probe Inc., San 
Diego, CA). To minimize the effects  of  endogenous cytokines,  cells 
were washed once in their respective culture medium without 
growth factor, resuspended to 4  x  10  s cells/ml, and incubated 
overnight at 37~  before experimentation. 
Normal Bone Marrow CD34 + Progenitor Cells.  Bone  marrow 
was collected from normal adult volunteers under a program ap- 
proved by the Human Ethics Committee of the Royal Adelaide 
Hospital. Bone  marrow samples were aspirated from donor sternum 
into heparinized (15 U/ml heparin; Wellcome, Beckenham, UK) 
tubes.  Aspirates were diluted in HBSS-FCS, and light density 
mononuclear cells were recovered over a density gradient (Lym- 
phoprep; Nycomed Pharmacia, Oslo, Norway). These cells were 
washed twice with HBSS-FCS, then incubated with HPCA-2-PE 
(anti-CD34, Becton Dickinson & Co., Mountain View, CA) at 
4~  for 45 min. Unbound HPCA-2-PE was removed with two 
washes, using HBSS-FCS, and the cells were transferred to a flow 
cytometer (FACStar|  Becton Dickinson & Co.) equipped with 
an argon laser emitting 488 nm light at 200 mW. CD34 § cells 
within the lymphocyte/blast region (21) were sorted into IMDM, 
supplemented with 50 Kunitz U/ml DNAse (No. D5025, Sigma 
Chemical Co.), and 20% FCS. A portion of the sorted cells was 
analyzed immediately  to assess purity and viability.  Cells were then 
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starved overnight at 37~  in the following serum-free medium: 
IMDM supplemented with  10 mg/ml BSA (No. A2153; Sigma 
Chemical Co.), 200/xg/ml iron-saturated human transferrin (No. 
T2158; Sigma Chemical Co.), 10/xg/ml insulin, 10/xg/ml low den- 
sity lipoproteins,  10 -5 M 2-ME. 
Adhesion  to Extracellular Matrix  Proteins.  96-well tissue cul- 
ture~treated plates (Nunc, Roskilde, Denmark) were incubated over- 
night at 4~  with 40/zl/well of PBS containing 50 #g/ml of ex- 
tracellular matrix proteins  (ECM): Fn,  collagen I, collagen IV, 
laminin, or vitronectin. The coating solution was removed by aspi- 
ration, replaced with 100/xl of KPMI 1640 containing 2% BSA, 
and incubated for a further 2 h at 37~  After this blocking step, 
plates were washed three times using RPMI 1640 containing 0.2% 
BSA, referred to as cell adhesion medium. At this stage, plates were 
chilled on ice and the adhesion assays  were performed within 20 win. 
Cells starved overnight without growth factor were harvested, 
washed twice, and resuspended in 500 #1 cell adhesion medium. 
50-100 #Ci of Na251CrO4 (New England Nuclear, Boston, MA) 
was added, and cells were incubated for 1 h at 37~  After radio- 
labeling, cells  were washed three times using adhesion  assay  medium, 
resuspended to 2-4  x  l0  s cells/ml, and chilled on ice for 10 min 
before assay. 100 #1 of the labeled cell suspension was placed in 
triplicate into ECM-coated wells. Growth factors were added at 
the specified  concentrations. The entire procedure was carried out 
on ice. Plates were centrifuged at 1,000 rpm for 5 min at 4~  to 
sediment cells into direct, uniform contact with treated surfaces. 
Plates were quickly warmed for 2 win to 37~  using a heating 
block before transfer to a humidified (100%) incubator at 37~ 
for the indicated periods. Assay medium was removed by aspira- 
tion and wells were washed three times by addition of 150/~1 of 
the adhesion assay medium and flicking off. After the last wash, 
cell adhesion and shape were examined using an inverted-contrast 
microscope before lysing in 150 #1 1% SDS, 1% NaOH solution. 
Lysates were  counted  after  10  rain,  using  a  gamma  counter. 
Nonspecific  cell adhesion was determined in wells treated with BSA 
only. The percentage of adherent cells was determined by dividing 
the activity in the adherent fraction by the radioactivity contained 
in 100 #1 of the initial labeled cell suspension. 
Cytometric Analysis of Antigen Expression.  The cell surface ex- 
pression  of adhesion  and  cytokine  receptors was  measured on 
CD34 § cells starved overnight at 37~  after treatment in suspen- 
sion with or without 10 ng/ml IL-3, GM-CSF, or KL, as described 
above. All the following staining procedures were performed on 
ice with ice-cold solutions. Immediately after the indicated incu- 
bation times with cytokines, cells were chilled on ice, pelleted, and 
resuspended in PBS containing 5% sheep serum and 0.1% NAN3. 
After 1 h incubation, cells were pelleted and resuspended in RPMI 
1640, 10%  FCS, 0.1%  NaN3 containing  equal volumes of hy- 
bridoma supernatants or a 1:100 dilution of ascites fluid. After a 
1-h incubation, cells were washed twice in PBS, 0.1% NaN3 and 
incubated for I h in a 1:100 dilution of fluorescein-conjugated  sheep 
F(ab)'2 fragments directed toward mouse Ig in RPMI 1640, 10% 
FCS, 0.1%  NAN3. Cells were then washed three times in PBS, 
0.1% NaN3 and fixed in 1% formaldehyde in PBS before analysis 
on an Epics-Profile II  (Coulter  Corp.,  Hialeah,  FL). Antibody 
binding was measured relative to isotype-matched, irrelevant con- 
trol antibodies. 
Results 
~i  Integrins Responsible for Attachment  of CD34 + Hemo- 
poietic Cells to Fn are in a Low Affinity State.  Previous studies 
have demonstrated that, despite the high level of expression 
of 31 integrins by human CD34 + progenitor cells, relatively 
few of these cells spontaneously attach to Fn (9, 22). In the 
current study, we sought to examine the mechanisms respon- 
sible for this apparent discrepancy and further to determine 
by what means the ~1 integrin-mediated adhesion of CD34 + 
cells to Fn could be increased. As a prelude to these investi- 
gations, we examined by flow cytometry the expression of 
31  integrins on normal bone marrow CD34 §  progenitor 
cells and to CD34 + cytokine-dependent cell lines TF1 and 
MO7e. In parallel,  we measured the adhesion of these cells 
to  immobilized intact  human  plasma  Fn.  In  accord with 
previous observations, although VLA-4 and VLA-5 were ex- 
pressed at high levels by all three populations (Table 1), only 
6.1%, 9.9%, and 10.0% of bone marrow CD34 + progen- 
itor, TF1, and MO7e cells, respectively, demonstrated spon- 
taneous adhesion to Fn (Table 2). However, after treatment 
with mAb 8A2, an anti-CD29 antibody shown by others to 
activate the ligand-binding function of 31 integrins through 
an "outside-in" mechanism (18, 23), all three populations of 
CD34 § cells exhibited markedly increased attachment to Fn 
(Table 2). Collectively, these data suggest that the majority 
of 31 integrins expressed by these cells are in a low affinity 
state incapable of binding immobilized Fn. 
Cytokine-induced Adhesion to Fn is Dose Dependent and Tran- 
sient.  Several studies have shown that integrin-function in 
CD34 + progenitor cells can be activated by various stimuli, 
such as PMA (9) or anti-CD31 polyclonal antibodies (24). 
Fig. 1 shows that a number of cytokines, including KL, IL-3, 
and GM-CSF, stimulate adhesion of MO7e and TF1 cells to 
Fn in a dose-dependent manner. IL-1, IL-6, and G-CSF were 
without effect over an equivalent range (data not shown). 
In the case of MO7e cells, half-maximal cytokine-stimulated 
adhesion to Fn was observed with 0.05 ng/ml GM-CSF, 0.3 
mg/ml KL, and 2 ng/ml IL-3, whereas, with TF1 cells, con- 
centrations of 0.03 ng/ml GM-CSF, 1 ng/ml KL, or 3 ng/ml 
IL-3 were required to stimulate half-maximal adhesion of  TF1 
ceils to Fn. Attachment to the control ligand, BSA (nonspecific 
binding), remained below 1% under all conditions (data not 
shown). 
In the absence of exogenous cytokine, the basal attachment 
of MO7e and TF1 cell lines in direct contact with plastic- 
immobilized Fn was maximal within 15 min incubation at 
37~  and remained stable with extended incubation (Fig. 
2). 8A2-treated cells bound Fn with similar saturation-binding 
kinetics and demonstrated stable adhesion over the 2-h time 
course of the assay. IL-3-, GM-CSF-, and KL-stimulated at- 
tachment to Fn was also maximal (three to four times basal 
levels) within 15-30 min incubation at 37~  but, in con- 
trast to 8A2-stimulated adhesion, was transient, returning 
to unstimulated levels after 2 h. 
In an attempt to understand the transient nature of  cytokine- 
stimulated attachment to Fn, we measured the expression of 
fll integrin and cytokine receptor expressions on TF1 and 
MO7e cell lines after a 2-h incubation in the presence of IL-3, 
GM-CSF,  or KL when cell adhesiveness  returned to close 
to basal level (Table 3). The transient nature of this adhesive- 
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mAb  Antigens  TF1  MO7e 
CeH lines 
CD34 § progenitors 
49.1Bll  E-selectin  0.291  0.304  0.10 
TS2/7  VLA-1  0.280  0.270  0.11 
AC  11  VLA-2  0.299  1.848  3.93 
PIB5  VLA-3  0.296  0.309  0.22 
P4C2  VLA-4  5.037  4.824  15.6 
PHM2  VLA-5  3.238  13.03  11.2 
GoH3  VLA-6  0.359  4.954  0.32 
61.2C4  CD29  8.666  20.13  29.6 
P3G8  CD51  0.800  2.904  0.19 
Cells were starved and labeled as described in Materials and Methods. Results are expressed as mean fluorescence  intensities. 
ness cannot be explained by a drop in the level of VLA-4 
or VLA-5 expression,  since they remained unaltered after a 
2-h incubation in the presence  of 10 ng/ml IL-3, GM-CSF, 
or KL. IL-3 receptor ot chains and the common ~c chains 
of IL-3 and GM-CSF receptors were not downregulated in 
both cell lines,  while GM-CSF receptor ot chain was par- 
tially downregulated by GM-CSF. Finally, the KIT receptor 
was strongly downregulated on TF1 cells by KL, but only 
partially on MO7e cells. 
Cytokine-stimulated Adhesion Is Refractory to Autologous,  but 
not Heterologous,  Secondary Stimulation.  To determine if cyto- 
kine-stimulated integrin activity was refractory to a secondary 
cytokine stimulation, TF1 cells were incubated for 2 h at 37~ 
in Fn-coated wells in the presence of 10 ng/ml GM-CSF, KL, 
or without cytokine, and then restimulated by a second ad- 
dition of cytokine when adhesion had returned to near-basal 
levels. Cells left for 2 h in the adhesion assay medium without 
Table  2.  mAb 8.42 Stimulates  MO7e,  TF1,  and Normal Bone 
Marrow CD34 § Hemopoietic Progenitor Cell Attachment  to Fn 
Stimuli 
Cell lines  Nil  8A2 
MO7e  10.0  +  1.1  83.6  _+  1.7 
0.6  +_  0.2  1.0  +_  0.I 
TF1  9.9  +  1.2  70.7  _+  1.5 
1.9  +_ 0.9  0.5  +_ 0.3 
Normal CD34 §  6.1  _+  1.0  83.1  +_  4.3 
progenitors  0.6  + 0.2  0.4  +_ 0.1 
Cell attachment to immobilized Fn and BSA (italics) was measured as 
described in Materials and Methods after a 20-min incubation at 37~ 
with or without 1/~g/ml 8A2 mAb. Data represent the mean _+ SEM. 
exogenously added cytokine remained responsive  to all the 
stimuli to the same extent as fresh cells. Cells treated with 
GM-CSF for 2 h could not be restimulated with either GM- 
CSF or IL-3 (Fig. 3).  These cells remained sensitive, how- 
ever, to stimulation with KL. Similarly, cells stimulated with 
KL were refractory to restimu|ation with KL, but remained 
sensitive to GM-CSF or IL-3. mAb 8A2 consistently induced 
maximal Fn attachment, irrespective  of any cytokine pre- 
treatment. 
MO7e- and TFl-augmented Adhesion Is Mediated by VLA-4 
and VLA-5.  The specificity of cytokine-activated adhesion 
of B1 integrins was tested for comparison with mAb 8A2, 
which activates  all ~1 integrins (18).  We analyzed/31 inte- 
grin-mediated cell adhesion to other ligands, including the 
ECM proteins, collagen types I and IV (VLA-1, VLA-2, and 
VLA-3),  Fn (VLA-4 and VLA-5),  laminin (VLA-6),  and 
vitronectin (c~v integrins) (25).  mAb 8A2 promotes MO7e 
cell adhesion to collagen I, Fn, laminin, and vitronectin (Fig. 
4 A). These cells were found to express their corresponding 
receptors,  VLA-2, -4,  -5,  -6,  and Otv integrins (Table 1). In 
contrast to mAb 8A2, cytokines selectively stimulated VLA-4 
and VLA-5 only (Fig.  4 A). The same selectivity was ob- 
served with TF1 cells (Fig. 4 B), which only express VLA-4, 
VLA-5, and otv integrins (Table 1). 
To characterize  the receptors  mediating cytokine-induced 
attachment to Fn, integrin-specific,  function-blocking anti- 
bodies were included in attachment assays. Attachment of 
MO7e cells to Fn induced by IL3, GM-CSF, and KL was 
completely inhibited by anti-VLA-5 mAb PHM2, indicating 
that VLA-5 is the primary Fn-receptor in stimulated cells. 
mAb P4C2, a function-blocking anti-VLA-4 mAb, only par- 
tially blocked MO7e adhesion to Fn (Fig. 5 A). The control 
mAb AC11, a function blocking anti-VLA-2 antibody, had 
no effect. The same experiment performed using TF1 cells 
showed attachment to Fn was only partially inhibited in the 
presence of PHM2 or P4C2 when used individually. Com- 
plete inhibition of cell attachment was observed only when 
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both PHM2 and P4C2 were present (Fig. 5 B). The presence 
of both antibodies together was required to inhibit cell adhe- 
sion to Fn induced by mAb 8A2 in all CD34 + cells.  In an- 
other experiment (not shown), we observed that 61.2C4,  a 
function blocking anti-CD29 (31 chain) mAb, was also able 
to block cytokine- and 8A2-induced MO7e and TF1 cell adhe- 
sion to Fn.  Collectively,  these data  show that VLA-4  and 
VLA-5 mediate both "inside-out"  and "outside-in" signal- 
enhanced attachment  to Fn. 
VLA-4- and VLA-5-mediated Enhanced  Adhesion Is Not Due 
to Changes in Cell Surface Expression.  Cytokine-augmented 
/ 
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Figure  1.  Cytokine-dependent 
activation of MO7e attachment to 
Fn is dose dependent.  MO7e  (A) 
and TF1 (B) cells were incubated for 
20 rain at 37~  in the presence of 
the indicated concentrations of IL3 
(O),  GM-CSF (I),  or KL (A). 
Data represent the mean  _+  SD of 
triplicate  samples  from a represen- 
tative experiment of four. 
cell attachment to Fn is rapid,  suggesting that VLA-4 and 
VLA-5 might be mobilized to the cell surface  from preex- 
isting intracellular  pools. To address this possibility, we ana- 
lyzed cell  surface  expression on MO7e  and TF1 cells  after 
a 20-min treatment with  10 ng/ml IL-3, GM-CSF,  or KL 
at 37~  Table 4 shows that the expression of CD29, VLA-4, 
VLA-5, and olv integrins was not dramatically  altered by the 
20-min cytokine  treatments. 
Cytokine-augmented Cell Adhesion Is Differentially Inhibited 
by Inhibitors of Second Messengers.  To clarify  the nature of 
the putative "inside-out" transduction pathways with a role 
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Figure  2.  Kinetics of adhesion 
on  Fn  induced  by  cytokines  and 
mAb 8A2. MO7e (A) and TF1 (B) 
cells were incubated at 37~  in the 
presence  of 10 ng/ml of IL3  (O), 
GM-CSF (B), KL (A), 1 /~g/ml 
8A2 mAb (0), or without stimulus 
(O).  At  the  indicated  times,  cell 
adhesion was measured in triplicate, 
as described  in Materials  and  Me- 
thods. This experiment is represen- 
tative of two experiments. 
1809  I.hvesque  et al. Table  3.  TF1  and MO7e Cell Antigen  Expression after a 2-h Incubation at 37~  with IL-3,  GM-CSF,  or KL 
TF1  MO7e 
mAb  Antigens  Nil  IL-3  GM-CSF  KL  Nil  IL-3  GM-CSF  KL 
49.1Bll  E-selectin  0.333  0.338  0.357  0.403  0.677  0.507  0.559  0.488 
YB5.B8  KIT/CD117  3.136  2.714  3.164  0.857  16.48  18.16  18.76  9.673 
3D7  ~c  5.194  5.444  5.569  4.962  0.949  0.712  0.717  0.775 
9F5  IL-3Rc~  1.336  1.195  1.429  1.092  1.089  0.975  1.062  1.057 
8G6  GM-CSFR-u  3.674  3.029  1.208  2.248  1.291  1.103  0.814  1.151 
P4C2  VLA-4  6.365  6.476  6.526  6.261  5.533  5.658  5.886  5.445 
PHM2  VLA-5  4.707  5.302  6.116  3.978  11.77  11.53  11.16  11.07 
P5D2  CD29  12.26  13.26  13.62  12.61  21.10  19.36  21.09  22.85 
Starved cells were treated as described in Materials and Methods and incubated at 37~  for 2 h without cytokine or in the presence of 10 ng/ml 
of IL-3, GM-CSF, or KL. Cells were then labeled  and analyzed  as described  in Materials and Methods. Results are expressed  as mean fluorescence  intensities. 
in the ~t  integrin  activation process,  we treated cells with 
inhibitors of putative second messenger pathways. As shown 
in Fig. 6, cholera toxin, an activator of adenylate cyclase (26), 
calyculin A, and okadaic acid, inhibitors of protein phospha- 
rases PP1 and PP2A (27, 28), failed to alter cytokine-augmented 
cell attachment to Fn. Conversely, staurosporine, a broad in- 
hibitor of protein kinases  (29),  and  WT,  a calmodulin  an- 
tagonist (30), strongly inhibited GM-CSF- and KL-induced 
attachment  to Fn.  Interestingly,  genistein,  a specific inhib- 
itor of tyrosine kinases (31), strongly inhibited KL-augmented 
adhesion  of  MO7e  and  TF1  cells  to  Fn,  whereas  GM- 
CSF-stimulated adhesion was only marginally affected, sug- 
gesting a divergence in cytokine-stimulated transduction path- 
ways. With the exception of WT, all inhibitors failed to alter 
8A2-induced cell adhesion, confirming its "outside-in" mode 
of action. 
Adhesiveness  of Steady-state  CD34 + Progenitors Is Increased 
by Cytokines.  Finally, we investigated whether cytokines also 
promoted  the  adhesion  of normal  bone  marrow  CD34 + 
progenitor cells to Fn. In agreement with the results obtained 
with the CD34 §  MO7e and TF1 cell lines, IL-3, GM-CSF, 
and KL significantly increased the binding of bone marrow 
CD34 + cells to Fn (Fig,  7). As observed with leukemic cell 
lines,  the activation was  transient,  since adhesion returned 
to the basal level after 150 rain. As with MO7e cells, cytokine- 
activated adhesiveness of normal progenitors was significantly 
but partially inhibited by the anti-VLA-4 P4C2 mAb with 
a 45-57% reduction of cell attachment, and was almost com- 
pletely blocked  by  the  anti-VLA-5  mAb  PHM2  with  an 
80-85% reduction. The combination of both of these mAbs 
completely abolished adhesion on Fn. Contrary to transformed 
cell lines,  normal ceils retained their round shape (data not 
shown). 
Figure 3.  Cytokine-stimulated  adhesion is refractory  to autologous, but 
not heterologous,  restimulation. TF1 ceils  were pretreated  for 2 h at 37~ 
in Fn-coated wells with either 10 ng/ml GM-CSF or 10 ng/ml KL, or 
in the absence  ofcytokine. Then, cells  were incubated for another 20-min 
period after the addition of 10 ng/ml IL-3 ([~B), GM-CSF (il), KL (B), 
1/~g/ml 8A2 mAb (i), or without  second stimulus ([-]). Cell attach- 
ment was measured  as described  in Materials and Methods. Data represent 
the mean _+  SD of triplicate samples from a representative  experiment 
of two. 
Discussion 
The physiological importance of interactions between hemo- 
poietic progenitors and the bone marrow stroma is well doc- 
umented,  although  little is known of the molecular events 
and the regulation of these events. "Inside-out" signals have 
been shown to modify integrin function, specificity, and ligand 
1810  Activation  of VLA-4 and VLA-5 by Cytokines Figure  4.  Cytokines selectively  increase cell adhesion to Fn. MO7e (A) 
and TF1 (B) cells were incubated in the presence of 10 ng/ml IL-3 (/~), 
GM-CSF (tit), KL (~),  1/zg/ml 8A2 mAb (R), or without  stimulus 
(l--l) in wells coated overnight with indicated ECM. Ceil attachment was 
measured as described in Materials and Methods at 37~  after 20 rain 
contact with immobilized proteins. Data represent the mean +  SD of 
triplicate samples from a representative experiment of two. 
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Figure  5.  Adhesion  of MO7e (A) and TF1 (B) cells on Fn is inhibited 
by P4C2 (anti-VLA-4)  and PHM2 (anti-VLA-5)  mAbs. Cells  were labeled 
with  51Cr, as described in Materials and Methods, and preincubated in 
suspension for 30 min at room temperature without  addition ([]) or in 
the presence of PHM2 (V~), P4C2 ([]), PHM2 and P4C2 (,), or AC11 
(IN), as described in Materials and Methods. Antibody-treated cells were 
transferred to Fn-coated  wells containing  10 ng/ml of the indicated cytokines 
or 1 #g/ml 8A2. Cell attachment was measured as described in Materials 
and Methods at 37~  after 20 min contact with immobilized Fn. Data 
represent the mean _+  SD of triplicate samples from a representative of 
two experiments. 
affinity in  other cellular  systems  (25,  32,  33).  This  is par- 
ticularly  well  documented  for  the  platelet  integrin  o/iib/33 
(34-36), fit integrins,  such as VLA-6 (37, 38), and 132 inte- 
grins, such as LFA-1 (39). Agonists which stimulate/31 inte- 
grin-mediated adhesiveness on hemopoietic and immune cells 
include activators of protein kinase C, such as PMA (9, 40), 
cross-linking  of antibodies  specific for CD31  (24,  41),  the 
T  cell receptor, CD7, CD28 (42), and certain activating anti- 
CD29  mAb  (18,  43-45). 
In this study, we show that hemopoietic cytokines, which 
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are more relevant physiological stimuli,  transiently increase 
the adhesive function of integrins VLA-4 and VLA-5 for their 
common ligand,  Fn.  VLA-4 and VLA-5 are normally ex- 
pressed by the CD34 +  cell lines  MO7e  and TF1 in  a low 
affinity configuration which bind Fn poorly. The magnitude 
of cell attachment to immobilized Fn stimulated by the anti- 
CD29 mAb 8A2 (18, 23) indicates that the majority of  VLA-4 
and VLA-5 on these cells is functionally inactive.  Similarly, 
VLA-4 and VLA-5 are inactive on steady-state normal bone 
marrow CD34 + progenitor cells  (9).  Therefore,  these adhe- Table 4.  TF1  and MO7e Integrin Expression after a 20-min  Activation  by GM-CSF or KL 
TF1  MO7e 
mAb  Antigens  Nil  IL-3  GM-CSF  KL  Nil  IL-3  GM-CSF  KL 
49.1Bll  E-selectin  0.362  0.322  0.296  0.312  0.590  0.640  0.612  0.565 
P4C2  VLA-4  4.888  5.552  5.267  5.130  4.119  5.262  5.629  5.110 
PHM2  VLA-5  3.294  3.298  3.877  3.804  10.07  9.711  10.85  10.95 
P5D2  CD29  10.07  10.85  10.33  10.38  18.47  18.10  21.72  20.57 
P3G8  CD51  1.366  1.371  1.456  1.433  3.333  2.845  3.348  4.019 
Starved cells  were treated  as described  in Materials and Methods and incubated  at 37~  for 20 min without cytokine  or in the presence  of 10 ng/ml 
of  IL-3, GM-CSF, or KL. Cells were then labeled  and analyzed  as described  in Materials and Methods. Results  are expressed  as mean  fluorescence  intensities. 
sive receptors require activation through a physiological mech- 
anism to function in vivo. Indeed, blocking anti-VLA-4 mAbs 
(11, 12, 46) and RGDS-containing peptides (13,  14) impair 
hemopoiesis both in vivo and in vitro, suggesting that VLA-4 
and VLA-5 must,  even transiently, exist in a high affinity 
Figure 6.  Effect  of inhibitors on MO7e cell adhesiveness  on Fn. After 
labeling with 51Cr, cells  were  preincubated  for 30 min at 37~  in the pres- 
ence of 50 #M W7, 0.5/zM staurosporine, 100 #M genistein, 0.2 #M 
okadaic acid, 0.2/xg/ml calyculin  A, or 0.2/~g/ml cholera  toxin. Then, 
cells were  plated  in Fn-coated  plates, as described  in Materials  and Methods, 
and incubated for 20 rain at 37~  in the absence ([[3), or presence, of 
10 ng/ml GM-CSF (~), 10 ng/ml KL (D), or 1 #g/ml 8A2 (11). Data 
represent the mean _+ SD of triplicate samples from a representative  of 
four experiments. 
state to be able to bind ligands and transduce specific signals 
that  regulate hemopoiesis. 
We have used  two  CD34 + cell lines,  MO7e and  TF1, 
which serve as models for hemopoietic progenitors, to inves- 
tigate the role of relevant cytokines in adhesive interactions 
between hemopoietic progenitor cells and their marrow micro- 
environment.  Indeed,  like  normal  bone  marrow  CD34 § 
progenitor cells, MO7e and TF1 are cytokine dependent (IL-3, 
GM-CSF, or KL) and express the V'LA-4 and VLA-5 receptors 
in a low affinity state.  We have shown that these cytokines 
transiently activate (Fig. 2), in a dose-dependent manner (Fig. 
1), both VLA-4 and VLA-5 enabling treated cells to interact 
with immobilized Fn. mAbs to both VLA-4 and VLA-5 are 
required to completely inhibit TF1 cell attachment to Fn, 
indicating  that  both  receptors contribute  to  the  adhesive 
phenotype in these cells. However, in MO7e and normal bone 
marrow  CD34 +  progenitor cells,  attachment  is  mediated 
primarily by VLA-5. This difference in integrin usage could 
be due to the relative levels of activated VLA-5 versus VLA-4 
in these different cell types. It is noteworthy that even with 
cytokine stimulation, not all available receptors are switched 
to the activated conformation. This is only achieved in the 
presence of mAb  8A2. 
Since the cell surface expression of VLA-4 and VLA-5 is 
unchanged by cytokine treatment, alterations in cell adhe- 
siveness likely result from modification of the affinity of  VLA-4 
and VLA-5 for their ligands.  Modification of integrin affinity 
could be regulated by "inside-out" signaling triggered by oc- 
cupancy of IL-3, GM-CSF, and KIT receptors. The transient 
nature of cytokine-stimulated activation is evidence for such 
a mechanism. Moreover, the transient nature of this cytokine- 
dependent activation cannot be explained by a correlated loss 
of cytokine receptor expression (Table 3), but rather by a mech- 
anism similar to the transient activation of protein kinases 
acting downstream of cytokine receptors, such as JAK2 (47), 
p42map  k and p44maP  k (48), p53/p56  lyn, or the phosphoinosi- 
tide 3OH kinase (49), the activities of which peak between 
5 and 15 min after cytokine stimulation. The nonphysiolog- 
ical activation conferred  by the mAb 8A2 induces an "outside- 
in" stable  change in the 31 chain conformation, leading to 
a stable increase of both VLA-4 and VLA-5 affinities for Fn 
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Figure 7.  Cytokines increase 
adhesion of normal bone marrow 
CD34 + hemopoietic progenitors 
to Fn. CD34  + donor bone marrow 
cells, enriched using FACS  |  and 
starved overnight  in  sernm-free 
medium, as described  in Materials 
and Methods, were  incubated  for 30 
rain (A) or 2.5 h (B) at 37~  in con- 
tact with Fn in the presence of the 
indicated concentrations of IL-3 
(,),  GM-CSF (0), or KL (&). 
Nonadherent cells  were  removed  as 
described and adherent cells were 
counted. These data represent the 
mean  _+ SD of triplicate samples 
from a representative  of two experi- 
ments. Adhesion on BSA remained 
below 1% in all the tested con- 
ditions. 
(23,  50).  This  is indicated  by the  action  of the blocking 
anti-VLA-4 and anti-VLA-5 mAbs, P4C2 and PHM2. Used 
individually, neither mAb is able to alter 8A2-activated cell 
adhesion to Fn; the combination of both being required to 
inhibit adhesiveness.  MO7e cells treated with 8A2 also ad- 
here to type I collagen via VLA-2, laminin via VLA-6, and 
vitronectin via c~v~l, yet fail to recognize these ECM ligands 
after treatment with IL-3, GM-CSF, or KL. Thus, mAb 8A2 
is a panactivator of/~1 integrins, whereas "inside-out" signals 
induced  by cytokines  selectively activate  ol4- and  c~5-con- 
taining  integrins. 
Our results demonstrate that  the activation pathway in- 
duced by cytokines requires some functional protein kinases 
other than cAMP-dependent  protein kinase,  while protein 
phosphatases PP1A and PP2B are unnecessary.  Indeed, stauro- 
sporine,  a broad inhibitor of protein kinases, completely abol- 
ished cytokine-mediated  B1 integrin  activation.  It is note- 
worthy that genistein,  a tyrosine kinase inhibitor,  strongly 
inhibited activation mediated by KIT, which is a tyrosine ki- 
nase receptor, while marginally inhibiting activation through 
the GM-CSF receptor, which does not possess any intrinsic 
tyrosine kinase activity. The protein kinases involved in this 
"inside-out" signaling pathway act downstream of the cytokine 
receptors and belong to an as yet undefined cascade leading 
to VLA-4 and VLA-5 activation. The molecular mechanism 
of ~1 integrin activation remains obscure, since/31  integrins 
are constitutively phosphorylated (l_~vesque,  J.-P., unpublished 
data). Furthermore,  there is no evidence that phosphoryla- 
tion is induced by, or as a consequence of, integrin activation 
or ligand binding (38, 51). cAMP-dependent protein kinase 
does not seem to belong to this "inside-out" pathway, since 
cholera toxin has no effect. On the other hand, it is not clear 
whether calmodulin-dependent  protein kinases are directly 
involved in  B1 integrin  activation  or in postreceptor cyto- 
skeletal rearrangements  leading to the strengthening  of cell 
adhesion  (51).  Indeed,  we noticed  that  W7,  a calmodulin 
antagonist, inhibited the cytokine-dependent induction of cell 
adhesion, but also partially inhibited 8A2-activated adhesive- 
ness. Moreover, after activation with mAb 8A2 in the pres- 
ence of W7, we noticed that  the adherent  cells retained a 
rounded shape, rather than the flattened morphology observed 
with or without the other inhibitors used in this study (not 
shown),  suggesting  an  effect on the cytoskeleton. 
It is tempting to speculate that this cytokine-regulated ac- 
tivation of VLA-4 and VLA-5 occurs with normal CD34 + 
bone marrow progenitors.  Several groups have shown that 
anti-VLA-4 antibodies strongly inhibit hemopoiesis both in 
vitro (11, 12) and in vivo (46), while RGDS-containing pep- 
tides reduce colony formation  in methyl cellulose cultures 
(13, 14). Moreover, in a previous study, Verfaillie et al. (22) 
have shown that long-term bone marrow cuhure-initiating 
cells, CFU-mix, burst-forming unit-E,  and CFU-GM, ad- 
here to intact Fn and that specific changes in adhesion to VLA- 
4- and VLA-5-binding  domains of Fn are associated with 
differentiation  of primitive multipotent progenitors into single 
lineage committed progenitors. In their study (22), the adhe- 
sion assays were performed in a serum-free medium without 
cytokine stimulation.  Significantly,  we have observed that, 
as with MO7e and TF1 cells, the adhesion of normal bone 
marrow CD34 + progenitors to Fn can be significantly aug- 
mented by IL-3, GM-CSF, and KL. This stimulation is tran- 
sient  and dose dependent. 
In conclusion, this work points to the intricate relation- 
ships between cytokine receptors and cytoadhesive receptors, 
and cell proliferation  and cell adhesion.  The  specificity of 
VLA-4 and VLA-5 integrin activation suggests an exquisite 
control of specific transduction pathways resulting in a subtle 
regulation of hemopoiesis at a molecular level.  The activa- 
tion  of ~1 integrins  and  augmentation  of cell adhesion  to 
specific ligands could be an important regulator of the prolifer- 
ation and differentiation of hemopoietic cells in response to 
cytokines. Conversely, the modulation of adhesive properties 
1813  l.~vesque  et al. by cytokines could be involved in the regulation of hemopoietic 
progenitor cell homing,  or release from the bone marrow, 
as observed in vivo with therapeutic protocols using perfu- 
sion of high  doses of cytokines (5,  52,  53). 
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